gastric cancer
Conditions
Interventions
None listed
Sponsors
Ishikawa prefectural central hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Candidate patients have to meet all the following inclusion criteria to participate in the study. (a)Histpathological investigation of the biopsy must confirm gastric cancer (Category 4 or 5 in the revised Vienna classification). (b)The gastric cancer will be treated by ESD for the first time. (c)Patients should be 20 years old and over.
Exclusion criteria
Exclusion criteria: (a)Patients who had undergone gastrectomy. (b)Patients in whom a gastric cancer is located in the junction of the esophagus and the stomach. (c)At the time of registration, HP-negative patients who have not had HP eradication. (d)At the time of registration, HP-negative patients in whom HP eradication is unidentified. (e)Patients who do not give informed consent.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The proportion of the delineation of the gastric cancer according to HP eradication or non-eradication that we able to diagnose exactly. | — |
Secondary
| Measure | Time frame |
|---|---|
| The proportion of the delineation of the gastric cancer according to a period of HP eradication that we were able to diagnose exactly. Frequency of the metachronous gastric cancers according to HP eradication or non-eradication. The proportion of the gastric cancer that fullfill tumor indication for endoscopic resection of Japanese gastric cancer treatment guidelines 2010 in semiannual surveillance after ESD. In addition, we will conduct exploratory and comprehensive analyses. | — |
Countries
Japan
Contacts
Public ContactKei Tominaga
Ishikawa prefectural central hospital Department of Gastroenterology
Outcome results
None listed